JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Lowered to $20 at JPMorgan
-
-
-
-
-
-
-
Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Prices 6.17M Share Offering at $81/sh
-
-
-
-
-
-
-
UPDATE: JPMorgan Upgrades Sarepta Therapeutics (SRPT) to Neutral
-
-
-
-
-
-
-
Pre-Open Movers 08/20: (HGV) (JCP) (BIDU) Higher; (SYBX) (SRPT) (FN) Lower (more...)
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock
-
276,561 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

